(opens in a new window)Fibralign Corporation is a private company producing advanced biomedical devices, utilizing its patented Nanoweave™ technology for creating 3D scaffolding which precisely mimics human tissue structure. This technology has been proven to directly influence desired cell behaviour and promote scarless wound healing and guided tissue regeneration. Fibralign’s proprietary process allows the manipulation of key parameters that drive liquid crystal proteins to self-assemble back to their natural formats. The technology stems from more than 10 years of research and development on oriented molecular thin film depositions, coupled with insights into fibrous proteins (primarily collagen) assembly into oriented structures.
Project Participants:
Greg King, CEO
Michael V. Paukshto, PhD
Tatiana S. Zaitseva, PhD